Moderna has initiated a Phase 1 clinical trial of an Ebola vaccine targeting the Bundibugyo strain, which is currently circulating in eastern Democratic Republic of the Congo, according to reports.
The ongoing Ebola outbreak in the Democratic Republic of the Congo, which The Zioneer reported on July 11 had reached 1,830 confirmed cases and 648 deaths, has been spreading across multiple provinces, including eastern areas where the Bundibugyo strain is circulating. Moderna's new Phase 1 trial targets this specific strain, marking a step in developing a vaccine tailored to the current outbreak. The trial's initiation follows months of international health alerts and containment efforts that have struggled to keep pace with the virus's spread.
- StrongDR Congo confirmed Ebola cases reach 1,830, including 648 deaths
- DevelopingDR Congo Ebola outbreak now worst in history, WHO says — 3,605 infected, 1,587 dead
- DevelopingWHO warns Ebola spreading faster than any previous outbreak in DR Congo
- DevelopingUK researchers test first AI-designed 'universal vaccine'
Source and signal
A single-sourced dispatch is never rated Confirmed or Strong. Its Signal strengthens only when a second, independent source corroborates it.
- Open-source intake